Live Breaking News & Updates on Groundbreaking Adaptive Clinical Trial Aims

Stay updated with breaking news from Groundbreaking adaptive clinical trial aims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

"Groundbreaking Adaptive Clinical Trial Aims to Reverse Neurological Damage in Progressive Multiple Sclerosis Patients" – The Republic Monitor

In a pioneering effort to address the limited treatment options for Australians grappling with progressive multiple sclerosis (MS), a groundbreaking adaptive clinical trial named PLATYPUS (PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis) is set to commence in January 2024. The initiative, boasting an initial funding of $4 million, marks the first-ever adaptive […] ....

United Kingdom , Simon Broadley , Melanie Kiely , Nigel Caswell , Griffith University School Of Medicine , United Kingdom Ms Society , Adaptive Trial , Multiple Sclerosis , Adaptive Clinical Trial Aims , Reverse Neurological Damage , Progressive Multiple Sclerosis , Groundbreaking Adaptive Clinical Trial Aims , Optimal Clinical Trials Platform , Multiple Sclerosis , Professor Simon Broadley , Chief Investigator , Griffith University , John Studdy Award ,